Skip to main content
OpenTrials
Completed

NCT Number: NCT04016272

Self-Administered Transcranial Direct Current Stimulation for Pain in Older Adults With Knee Osteoarthritis

The purpose of this study is to assess the feasibility, acceptability, and efficacy of self-administered transcranial direct current stimulation (tDCS) in older adults with knee osteoarthritis (OA)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteo Arthritis Knee

Age range

50 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • have symptomatic knee OA based on American College of Rheumatology Clinical criteria
  • have had knee OA pain in the past 3 months with an average of at least 30 on a 0-100 NRS for pain
  • can speak and read English
  • have no plan to change medication regimens for pain throughout the trial

Exclusion criteria

  • prosthetic knee replacement or nonarthroscopic surgery to the affected knee
  • history of brain surgery, brain tumor, seizure, stroke or intracranial metal implantation
  • systemic rheumatic disorders, including rheumatoid arthritis, systemic lupus erythematosus, and fibromyalgia
  • alcohol/substance abuse
  • current use of sodium channel blockers, calcium channel blockers and NMDS receptor antagonists
  • diminished cognitive function that would interfere with understanding study procedures(i.e., Mini-Mental Status Exam score ≤ 23)
  • pregnancy or lactation
  • hospitalization within the preceding year for psychiatric illness
  • no access to a device with internet access that can be used for secure videoconferencing for real-time remote supervision

Treatment and study plan

active tDCS

Device

tDCS with a constant current intensity of 2 mA will be applied for 20 minutes per session daily for 2 weeks (Monday to Friday) via the Soterix 1x1 tDCS mini-CT Stimulator device (Soterix Medical Inc., NY) with headgear and saline-soaked surface sponge electrodes.

Other names: Soterix 1x1 tDCS mini-CT Stimulator

Sham tDCS

Device

For sham stimulation, the electrodes will be placed in the same positions as for active stimulation, but the stimulator will only deliver 2 mA current for 30 seconds.

Other names: Soterix 1x1 tDCS mini-CT Stimulator

Primary outcomes

  1. Change in Clinical Pain as Assessed by the Numeric Rating Scale (NRS) for Pain

    Time frame: baseline, week 3

    The Numeric Rating Scale (NRS) total score ranges from 0 (no pain) to 100 (most intense pain imaginable).

Secondary outcomes

  1. Change in Pain Related Cortical Response Using a Continuous Wave, Multichannel Functional Near-infrared Spectroscopy (fNIRS) Imaging System

    Time frame: Baseline, week1, week2, and week 3

    Pain-related cortical response will be measured using a continuous-wave, multichannel fNIRS imaging system (LIGHTNIRS, Shimadzu, Kyoto, Japan) with three semiconductor lasers at 780, 805, and 830 nm. Optical recordings will be collected during thermal and punctate pain stimulation and correlation values will be presented in the form of figures.

    • Specify the full scale: Pearson correlation coefficient (r) between pairs of brain regions (fNIRS channels).
    • A value of r=0 indicates that two brain regions were functionally disconnected.
    • Greater absolute r values denote stronger connections. However, this does not indicate a better or worse result but only a different type of connectivity on a macroscale (when considering several fNIRS channels).
    • We used |r|>0.3 (absolute value of r greater than 0.3) to extract meaningful functional connections.

  2. Acceptability as Measured by the tDCs Experience Questionnaire

    Time frame: week 3

    The tDCS experience questionnaire contains 10 questions based on a scale from 0-10, 0 being strongly disagree and 10 being strongly agree.

    Higher scores indicating greater acceptability for 7 questions and lower scores indicating greater acceptability for 3 questions resulting most desirable score of a 70.

  3. Number of Participants With Possible Side Effects of Treatment

    Time frame: week 3

    If any side effects are reported, the degree of relatedness to the intervention will be assessed on a 10-point scale, from 0 (not at all) to 10 (to a high degree). The questionnaire ask to what extend did the participant experienced symptoms like, tingling, itching sensation, burning sensation, pain at the stimulation site, fatigue, nervousness, headache, difficulty concentrating, or mood change.

  4. Feasibility as Assessed by the Number of Participants That Complete the Full tDCS Protocol

    Time frame: week 3

    We will calculate the percentage of participants who a) meet the inclusion criteria, b) agree to be randomly assigned, c) complete the full tDCS protocol, and d) attend the follow-up assessment.

Sponsors and collaborators

Lead sponsor

Florida State University

Other

Collaborators

  • National Institute of Nursing Research (NINR)

Registry information

Official study title

Self-Administered Transcranial Direct Current Stimulation for Pain in Older Adults With Knee Osteoarthritis: A Phase II Randomized Sham-Controlled Trial

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Jul 11, 2019
Registry last updated
May 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.